← ANALYST RATINGS · TIPRANKS
Carlsmed, Inc. (CARL): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy0 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is —, the highest —, the lowest —. The average is — from the last price of $13.41.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $23.00 → $24.00+4.3% | Buy | +79.0% | Reiterated | 12.10.26on TipRanks 08:35 | +2.6%next day −2.1% | ↗ |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $16.00 → $13.50−15.6% | Hold | +0.7% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $16.50 → $14.50−12.1% | Hold | +8.1% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $16.00 → $14.00−12.5% | Hold | +4.4% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $16.00 → $14.00−12.5% | Hold | +4.4% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $16.50 → $14.50−12.1% | Hold | +8.1% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $15.50 → $14.00−9.7% | Hold | +4.4% | Reiterated | 30.09.26on TipRanks 17:05 | — | |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | — | Buy | — | Reiterated | 29.09.26on TipRanks 08:11 | −0.5%next day +0.1% · 5 days +2.0% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | — | Buy | — | Reiterated | 13.08.26on TipRanks 11:25 | +1.3%next day +2.6% · 5 days +19.9% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $18.00 | Buy | +34.2% | Reiterated | 06.08.26on TipRanks 07:00 | +1.2%next day +0.3% · 5 days +0.9% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $17.00 | Buy | +26.8% | Reiterated | 06.08.26on TipRanks 06:55 | +1.2%next day +0.3% · 5 days +0.9% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $17.00 → $16.00−5.9% | Buy | +19.3% | Reiterated | 05.05.26on TipRanks May 6 07:30 | −2.7%next day +8.9% · 5 days +8.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Carlsmed, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $19.33 at a price of $14.07 (+37.4%); now: $19.67 at $13.41 (+46.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.39 (from $-0.42 to $-0.36). Last quarter: $-0.39.
Sales
Next quarter’s sales estimate — $19M (from $18M to $20M). Last quarter: $19M.
Best top-analyst consensus in the sector · General
About Carlsmed, Inc.
- CEO: Michael Cordonnier
- Employees: 127
- 1800 Aston Avenue, Carlsbad, CA, 92008, US
- www.carlsmed.com
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Data from the stock’s TipRanks forecast page, read 86 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗